Panel discussion to explore competitive differentiation as AI reshapes drug discovery and development; TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Com ...
EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis ...
When researchers measure the activity of thousands of genes at once, they face a paradox that has shaped computational biology for decades: far too many variables and far too few samples. A single DNA ...
GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will introduce Easy Order at the 2026 American Academy of Pediatrics (AAP) ...
EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis framework beyond methylation microarrays to sequencing-derived DNA ...
An article in Molecular Ecology describes the factors shaping microbial eukaryotic populations and their role in the carbon cycle at deep-sea hydrothermal vents.
The Global Bioinformatics Market was valued at USD 20.34 Billion in 2025 and is projected to expand at a 13.7% CAGR from 2026 ...
The molecular diagnostics market size is valued at USD 17.6 billion in 2025 and is projected to reach USD 36.2 billion by the end of 2035, with a compound annual growth rate (CAGR) of 7.4% during the ...
Feature selection (FS) is a critical step in hyperspectral image (HSI) classification, essential for reducing data dimensionality while preserving classification accuracy. However, FS for HSIs remains ...
The following biotech stocks reached a 52-week high on September 16, 2026, driven by positive results from clinical trials or an upcoming conference participation. BlossomHill Therapeutics is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results